Results 21 to 30 of about 1,349,118 (267)

Trust and legitimacy across Europe: a FIDUCIA report on comparative public attitudes towards legal authority [PDF]

open access: yes, 2013
FIDUCIA (New European Crimes and Trust-based Policy) seeks to shed light on a number of distinctively ‘new European’ criminal behaviours which have emerged in the last decade as a consequence of both technology developments and the increased mobility of ...
Bradford, Ben   +5 more
core   +1 more source

The Effect of Different Intensities of Acute Aerobic Exercise on Plasma Resistin Concentration and Insulin Resistance Index in Type 2 Diabetic Males [PDF]

open access: yesJournal of Advanced Biomedical Sciences, 2016
Background & Objectives: Today, the increase in diabetes all over the world and positive results of locomotor activity and exercise on factors related to this disease have been taken into consideration.
Ziba Davoudi   +3 more
doaj   +2 more sources

On the robustness of the H$\beta$ Lick index as a cosmic clock in passive early-type galaxies [PDF]

open access: yes, 2017
We examine the H$\beta$ Lick index in a sample of $\sim 24000$ massive ($\rm log(M/M_{\odot})>10.75$) and passive early-type galaxies extracted from SDSS at ...
Cimatti, A.   +3 more
core   +3 more sources

THE LEGAL REGIME FOR CUSTOMS DUTIES AND TAXES HAVING EQUIVALENT EFFECT IN THE EUROPEAN UNION [PDF]

open access: yesChallenges of the Knowledge Society, 2018
One of the consequences that generates direct, short, medium and long-term effects, determined by the accession of the states to the European Union, is that of valorizing also the free movement of goods.
Augustin FUEREA
doaj  

A multicomponent intervention to reduce daily sitting time in office workers: the SMART Work & Life three-arm cluster RCT

open access: yesPublic Health Research, 2023
Background Office workers spend 70–85% of their time at work sitting. High levels of sitting have been linked to poor physiological and psychological health. Evidence shows the need for fully powered randomised controlled trials, with long-term follow-up,
Edwardson Charlotte L   +19 more
doaj   +1 more source

Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval

open access: yesACR Open Rheumatology, 2022
Journal Club Furie R, Khamashta M, Merrill JT, Werth VP, Kalunian K, Brohawn P, et al. Anifrolumab, an anti‐interferon‐α receptor monoclonal antibody, in moderate‐to‐severe systemic lupus erythematosus. Arthritis Rheumatol 2017;69:376‐86.
Michael F. Loncharich, Caleb W. Anderson
doaj   +1 more source

The TASEP speed process

open access: yes, 2012
In the multi-type totally asymmetric simple exclusion process (TASEP) on the line, each site of Z is occupied by a particle labeled with some number, and two neighboring particles are interchanged at rate one if their labels are in increasing order ...
Amir, Gideon   +2 more
core   +1 more source

Construct-level predictive validity of educational attainment and intellectual aptitude tests in medical student selection: meta-regression of six UK longitudinal studies [PDF]

open access: yes, 2013
Background: Measures used for medical student selection should predict future performance during training. A problem for any selection study is that predictor-outcome correlations are known only in those who have been selected, whereas selectors need to ...
Admissions to Higher Education Steering Group   +71 more
core   +5 more sources

Health‐Related Quality of Life and Symptom Severity Among Patients With PIK3CA‐Related Overgrowth Spectrum: A Mixed‐Methods Study to Understand Real‐World Experience With Alpelisib Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background PIK3CA‐related overgrowth spectrum (PROS) includes several rare overgrowth disorders resulting from somatic gain‐of‐function mutations in PIK3CA. Despite treatment advances, including the recent approval of alpelisib for PROS in the United States, literature detailing the patient experience with PROS is limited.
Vamsi Bollu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy